Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.24.2.u1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Concentration Risk [Line Items]        
Revenues $ 88,765 $ 83,635 $ 166,790 $ 155,797
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 58,234 60,343 110,224 113,533
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 30,531 $ 23,292 $ 56,566 $ 42,264